Pharma & Healthcare

Global Paclitaxel Drug Market Insights, Forecast to 2030

Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".
The global Paclitaxel Drug market is projected to grow from US$ 120.8 million in 2024 to US$ 139.3 million by 2030, at a Compound Annual Growth Rate (CAGR) of 2.4% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Paclitaxel Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Paclitaxel Drug, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Paclitaxel Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Paclitaxel Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Paclitaxel Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Paclitaxel Drug sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Celgene
Jiangsu Hengrui
Bristol-Myers Squibb
Pfizer
Teva
Mylan
Novartis
Segment by Type
30mg
100mg
Segment by Application
Hospital
Drugs Store
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Paclitaxel Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Paclitaxel Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Paclitaxel Drug sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Paclitaxel Drug Product Introduction
1.2 Market by Type
1.2.1 Global Paclitaxel Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 30mg
1.2.3 100mg
1.3 Market by Application
1.3.1 Global Paclitaxel Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Drugs Store
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Paclitaxel Drug Sales Estimates and Forecasts 2019-2030
2.2 Global Paclitaxel Drug Revenue by Region
2.2.1 Global Paclitaxel Drug Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Paclitaxel Drug Revenue by Region (2019-2024)
2.2.3 Global Paclitaxel Drug Revenue by Region (2025-2030)
2.2.4 Global Paclitaxel Drug Revenue Market Share by Region (2019-2030)
2.3 Global Paclitaxel Drug Sales Estimates and Forecasts 2019-2030
2.4 Global Paclitaxel Drug Sales by Region
2.4.1 Global Paclitaxel Drug Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Paclitaxel Drug Sales by Region (2019-2024)
2.4.3 Global Paclitaxel Drug Sales by Region (2025-2030)
2.4.4 Global Paclitaxel Drug Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Paclitaxel Drug Sales by Manufacturers
3.1.1 Global Paclitaxel Drug Sales by Manufacturers (2019-2024)
3.1.2 Global Paclitaxel Drug Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Paclitaxel Drug in 2023
3.2 Global Paclitaxel Drug Revenue by Manufacturers
3.2.1 Global Paclitaxel Drug Revenue by Manufacturers (2019-2024)
3.2.2 Global Paclitaxel Drug Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Paclitaxel Drug Revenue in 2023
3.3 Global Key Players of Paclitaxel Drug, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Paclitaxel Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Paclitaxel Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Paclitaxel Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Paclitaxel Drug, Product Offered and Application
3.8 Global Key Manufacturers of Paclitaxel Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Paclitaxel Drug Sales by Type
4.1.1 Global Paclitaxel Drug Historical Sales by Type (2019-2024)
4.1.2 Global Paclitaxel Drug Forecasted Sales by Type (2025-2030)
4.1.3 Global Paclitaxel Drug Sales Market Share by Type (2019-2030)
4.2 Global Paclitaxel Drug Revenue by Type
4.2.1 Global Paclitaxel Drug Historical Revenue by Type (2019-2024)
4.2.2 Global Paclitaxel Drug Forecasted Revenue by Type (2025-2030)
4.2.3 Global Paclitaxel Drug Revenue Market Share by Type (2019-2030)
4.3 Global Paclitaxel Drug Price by Type
4.3.1 Global Paclitaxel Drug Price by Type (2019-2024)
4.3.2 Global Paclitaxel Drug Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Paclitaxel Drug Sales by Application
5.1.1 Global Paclitaxel Drug Historical Sales by Application (2019-2024)
5.1.2 Global Paclitaxel Drug Forecasted Sales by Application (2025-2030)
5.1.3 Global Paclitaxel Drug Sales Market Share by Application (2019-2030)
5.2 Global Paclitaxel Drug Revenue by Application
5.2.1 Global Paclitaxel Drug Historical Revenue by Application (2019-2024)
5.2.2 Global Paclitaxel Drug Forecasted Revenue by Application (2025-2030)
5.2.3 Global Paclitaxel Drug Revenue Market Share by Application (2019-2030)
5.3 Global Paclitaxel Drug Price by Application
5.3.1 Global Paclitaxel Drug Price by Application (2019-2024)
5.3.2 Global Paclitaxel Drug Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Paclitaxel Drug Market Size by Type
6.1.1 US & Canada Paclitaxel Drug Sales by Type (2019-2030)
6.1.2 US & Canada Paclitaxel Drug Revenue by Type (2019-2030)
6.2 US & Canada Paclitaxel Drug Market Size by Application
6.2.1 US & Canada Paclitaxel Drug Sales by Application (2019-2030)
6.2.2 US & Canada Paclitaxel Drug Revenue by Application (2019-2030)
6.3 US & Canada Paclitaxel Drug Market Size by Country
6.3.1 US & Canada Paclitaxel Drug Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Paclitaxel Drug Sales by Country (2019-2030)
6.3.3 US & Canada Paclitaxel Drug Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Paclitaxel Drug Market Size by Type
7.1.1 Europe Paclitaxel Drug Sales by Type (2019-2030)
7.1.2 Europe Paclitaxel Drug Revenue by Type (2019-2030)
7.2 Europe Paclitaxel Drug Market Size by Application
7.2.1 Europe Paclitaxel Drug Sales by Application (2019-2030)
7.2.2 Europe Paclitaxel Drug Revenue by Application (2019-2030)
7.3 Europe Paclitaxel Drug Market Size by Country
7.3.1 Europe Paclitaxel Drug Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Paclitaxel Drug Sales by Country (2019-2030)
7.3.3 Europe Paclitaxel Drug Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Paclitaxel Drug Market Size
8.1.1 China Paclitaxel Drug Sales (2019-2030)
8.1.2 China Paclitaxel Drug Revenue (2019-2030)
8.2 China Paclitaxel Drug Market Size by Application
8.2.1 China Paclitaxel Drug Sales by Application (2019-2030)
8.2.2 China Paclitaxel Drug Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Paclitaxel Drug Market Size by Type
9.1.1 Asia Paclitaxel Drug Sales by Type (2019-2030)
9.1.2 Asia Paclitaxel Drug Revenue by Type (2019-2030)
9.2 Asia Paclitaxel Drug Market Size by Application
9.2.1 Asia Paclitaxel Drug Sales by Application (2019-2030)
9.2.2 Asia Paclitaxel Drug Revenue by Application (2019-2030)
9.3 Asia Paclitaxel Drug Sales by Region
9.3.1 Asia Paclitaxel Drug Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Paclitaxel Drug Revenue by Region (2019-2030)
9.3.3 Asia Paclitaxel Drug Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Paclitaxel Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Paclitaxel Drug Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Paclitaxel Drug Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Paclitaxel Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Paclitaxel Drug Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Paclitaxel Drug Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Paclitaxel Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Paclitaxel Drug Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Paclitaxel Drug Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Paclitaxel Drug Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Luye Pharma
11.1.1 Luye Pharma Company Information
11.1.2 Luye Pharma Overview
11.1.3 Luye Pharma Paclitaxel Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Luye Pharma Paclitaxel Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Luye Pharma Recent Developments
11.2 CSPC Company
11.2.1 CSPC Company Company Information
11.2.2 CSPC Company Overview
11.2.3 CSPC Company Paclitaxel Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 CSPC Company Paclitaxel Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CSPC Company Recent Developments
11.3 Celgene
11.3.1 Celgene Company Information
11.3.2 Celgene Overview
11.3.3 Celgene Paclitaxel Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Celgene Paclitaxel Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Celgene Recent Developments
11.4 Jiangsu Hengrui
11.4.1 Jiangsu Hengrui Company Information
11.4.2 Jiangsu Hengrui Overview
11.4.3 Jiangsu Hengrui Paclitaxel Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Jiangsu Hengrui Paclitaxel Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Jiangsu Hengrui Recent Developments
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Information
11.5.2 Bristol-Myers Squibb Overview
11.5.3 Bristol-Myers Squibb Paclitaxel Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Bristol-Myers Squibb Paclitaxel Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Bristol-Myers Squibb Recent Developments
11.6 Pfizer
11.6.1 Pfizer Company Information
11.6.2 Pfizer Overview
11.6.3 Pfizer Paclitaxel Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Pfizer Paclitaxel Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Pfizer Recent Developments
11.7 Teva
11.7.1 Teva Company Information
11.7.2 Teva Overview
11.7.3 Teva Paclitaxel Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Teva Paclitaxel Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Teva Recent Developments
11.8 Mylan
11.8.1 Mylan Company Information
11.8.2 Mylan Overview
11.8.3 Mylan Paclitaxel Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Mylan Paclitaxel Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Mylan Recent Developments
11.9 Novartis
11.9.1 Novartis Company Information
11.9.2 Novartis Overview
11.9.3 Novartis Paclitaxel Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Novartis Paclitaxel Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Novartis Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Paclitaxel Drug Industry Chain Analysis
12.2 Paclitaxel Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Paclitaxel Drug Production Mode & Process
12.4 Paclitaxel Drug Sales and Marketing
12.4.1 Paclitaxel Drug Sales Channels
12.4.2 Paclitaxel Drug Distributors
12.5 Paclitaxel Drug Customers
13 Market Dynamics
13.1 Paclitaxel Drug Industry Trends
13.2 Paclitaxel Drug Market Drivers
13.3 Paclitaxel Drug Market Challenges
13.4 Paclitaxel Drug Market Restraints
14 Key Findings in The Global Paclitaxel Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Paclitaxel Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of 30mg
Table 3. Major Manufacturers of 100mg
Table 4. Global Paclitaxel Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global Paclitaxel Drug Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Paclitaxel Drug Revenue by Region (2019-2024) & (US$ Million)
Table 7. Global Paclitaxel Drug Revenue by Region (2025-2030) & (US$ Million)
Table 8. Global Paclitaxel Drug Revenue Market Share by Region (2019-2024)
Table 9. Global Paclitaxel Drug Revenue Market Share by Region (2025-2030)
Table 10. Global Paclitaxel Drug Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 11. Global Paclitaxel Drug Sales by Region (2019-2024) & (K Units)
Table 12. Global Paclitaxel Drug Sales by Region (2025-2030) & (K Units)
Table 13. Global Paclitaxel Drug Sales Market Share by Region (2019-2024)
Table 14. Global Paclitaxel Drug Sales Market Share by Region (2025-2030)
Table 15. Global Paclitaxel Drug Sales by Manufacturers (2019-2024) & (K Units)
Table 16. Global Paclitaxel Drug Sales Share by Manufacturers (2019-2024)
Table 17. Global Paclitaxel Drug Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 18. Global Paclitaxel Drug Revenue Share by Manufacturers (2019-2024)
Table 19. Global Key Players of Paclitaxel Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 20. Paclitaxel Drug Price by Manufacturers 2019-2024 (US$/Unit)
Table 21. Global Paclitaxel Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Paclitaxel Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paclitaxel Drug as of 2023)
Table 23. Global Key Manufacturers of Paclitaxel Drug, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Paclitaxel Drug, Product Offered and Application
Table 25. Global Key Manufacturers of Paclitaxel Drug, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Paclitaxel Drug Sales by Type (2019-2024) & (K Units)
Table 28. Global Paclitaxel Drug Sales by Type (2025-2030) & (K Units)
Table 29. Global Paclitaxel Drug Sales Share by Type (2019-2024)
Table 30. Global Paclitaxel Drug Sales Share by Type (2025-2030)
Table 31. Global Paclitaxel Drug Revenue by Type (2019-2024) & (US$ Million)
Table 32. Global Paclitaxel Drug Revenue by Type (2025-2030) & (US$ Million)
Table 33. Global Paclitaxel Drug Revenue Share by Type (2019-2024)
Table 34. Global Paclitaxel Drug Revenue Share by Type (2025-2030)
Table 35. Paclitaxel Drug Price by Type (2019-2024) & (US$/Unit)
Table 36. Global Paclitaxel Drug Price Forecast by Type (2025-2030) & (US$/Unit)
Table 37. Global Paclitaxel Drug Sales by Application (2019-2024) & (K Units)
Table 38. Global Paclitaxel Drug Sales by Application (2025-2030) & (K Units)
Table 39. Global Paclitaxel Drug Sales Share by Application (2019-2024)
Table 40. Global Paclitaxel Drug Sales Share by Application (2025-2030)
Table 41. Global Paclitaxel Drug Revenue by Application (2019-2024) & (US$ Million)
Table 42. Global Paclitaxel Drug Revenue by Application (2025-2030) & (US$ Million)
Table 43. Global Paclitaxel Drug Revenue Share by Application (2019-2024)
Table 44. Global Paclitaxel Drug Revenue Share by Application (2025-2030)
Table 45. Paclitaxel Drug Price by Application (2019-2024) & (US$/Unit)
Table 46. Global Paclitaxel Drug Price Forecast by Application (2025-2030) & (US$/Unit)
Table 47. US & Canada Paclitaxel Drug Sales by Type (2019-2024) & (K Units)
Table 48. US & Canada Paclitaxel Drug Sales by Type (2025-2030) & (K Units)
Table 49. US & Canada Paclitaxel Drug Revenue by Type (2019-2024) & (US$ Million)
Table 50. US & Canada Paclitaxel Drug Revenue by Type (2025-2030) & (US$ Million)
Table 51. US & Canada Paclitaxel Drug Sales by Application (2019-2024) & (K Units)
Table 52. US & Canada Paclitaxel Drug Sales by Application (2025-2030) & (K Units)
Table 53. US & Canada Paclitaxel Drug Revenue by Application (2019-2024) & (US$ Million)
Table 54. US & Canada Paclitaxel Drug Revenue by Application (2025-2030) & (US$ Million)
Table 55. US & Canada Paclitaxel Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. US & Canada Paclitaxel Drug Revenue by Country (2019-2024) & (US$ Million)
Table 57. US & Canada Paclitaxel Drug Revenue by Country (2025-2030) & (US$ Million)
Table 58. US & Canada Paclitaxel Drug Sales by Country (2019-2024) & (K Units)
Table 59. US & Canada Paclitaxel Drug Sales by Country (2025-2030) & (K Units)
Table 60. Europe Paclitaxel Drug Sales by Type (2019-2024) & (K Units)
Table 61. Europe Paclitaxel Drug Sales by Type (2025-2030) & (K Units)
Table 62. Europe Paclitaxel Drug Revenue by Type (2019-2024) & (US$ Million)
Table 63. Europe Paclitaxel Drug Revenue by Type (2025-2030) & (US$ Million)
Table 64. Europe Paclitaxel Drug Sales by Application (2019-2024) & (K Units)
Table 65. Europe Paclitaxel Drug Sales by Application (2025-2030) & (K Units)
Table 66. Europe Paclitaxel Drug Revenue by Application (2019-2024) & (US$ Million)
Table 67. Europe Paclitaxel Drug Revenue by Application (2025-2030) & (US$ Million)
Table 68. Europe Paclitaxel Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 69. Europe Paclitaxel Drug Revenue by Country (2019-2024) & (US$ Million)
Table 70. Europe Paclitaxel Drug Revenue by Country (2025-2030) & (US$ Million)
Table 71. Europe Paclitaxel Drug Sales by Country (2019-2024) & (K Units)
Table 72. Europe Paclitaxel Drug Sales by Country (2025-2030) & (K Units)
Table 73. China Paclitaxel Drug Sales by Type (2019-2024) & (K Units)
Table 74. China Paclitaxel Drug Sales by Type (2025-2030) & (K Units)
Table 75. China Paclitaxel Drug Revenue by Type (2019-2024) & (US$ Million)
Table 76. China Paclitaxel Drug Revenue by Type (2025-2030) & (US$ Million)
Table 77. China Paclitaxel Drug Sales by Application (2019-2024) & (K Units)
Table 78. China Paclitaxel Drug Sales by Application (2025-2030) & (K Units)
Table 79. China Paclitaxel Drug Revenue by Application (2019-2024) & (US$ Million)
Table 80. China Paclitaxel Drug Revenue by Application (2025-2030) & (US$ Million)
Table 81. Asia Paclitaxel Drug Sales by Type (2019-2024) & (K Units)
Table 82. Asia Paclitaxel Drug Sales by Type (2025-2030) & (K Units)
Table 83. Asia Paclitaxel Drug Revenue by Type (2019-2024) & (US$ Million)
Table 84. Asia Paclitaxel Drug Revenue by Type (2025-2030) & (US$ Million)
Table 85. Asia Paclitaxel Drug Sales by Application (2019-2024) & (K Units)
Table 86. Asia Paclitaxel Drug Sales by Application (2025-2030) & (K Units)
Table 87. Asia Paclitaxel Drug Revenue by Application (2019-2024) & (US$ Million)
Table 88. Asia Paclitaxel Drug Revenue by Application (2025-2030) & (US$ Million)
Table 89. Asia Paclitaxel Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 90. Asia Paclitaxel Drug Revenue by Region (2019-2024) & (US$ Million)
Table 91. Asia Paclitaxel Drug Revenue by Region (2025-2030) & (US$ Million)
Table 92. Asia Paclitaxel Drug Sales by Region (2019-2024) & (K Units)
Table 93. Asia Paclitaxel Drug Sales by Region (2025-2030) & (K Units)
Table 94. Middle East, Africa and Latin America Paclitaxel Drug Sales by Type (2019-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Paclitaxel Drug Sales by Type (2025-2030) & (K Units)
Table 96. Middle East, Africa and Latin America Paclitaxel Drug Revenue by Type (2019-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Paclitaxel Drug Revenue by Type (2025-2030) & (US$ Million)
Table 98. Middle East, Africa and Latin America Paclitaxel Drug Sales by Application (2019-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Paclitaxel Drug Sales by Application (2025-2030) & (K Units)
Table 100. Middle East, Africa and Latin America Paclitaxel Drug Revenue by Application (2019-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Paclitaxel Drug Revenue by Application (2025-2030) & (US$ Million)
Table 102. Middle East, Africa and Latin America Paclitaxel Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 103. Middle East, Africa and Latin America Paclitaxel Drug Revenue by Country (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Paclitaxel Drug Revenue by Country (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America Paclitaxel Drug Sales by Country (2019-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Paclitaxel Drug Sales by Country (2025-2030) & (K Units)
Table 107. Luye Pharma Company Information
Table 108. Luye Pharma Description and Major Businesses
Table 109. Luye Pharma Paclitaxel Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Luye Pharma Paclitaxel Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Luye Pharma Recent Developments
Table 112. CSPC Company Company Information
Table 113. CSPC Company Description and Major Businesses
Table 114. CSPC Company Paclitaxel Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. CSPC Company Paclitaxel Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. CSPC Company Recent Developments
Table 117. Celgene Company Information
Table 118. Celgene Description and Major Businesses
Table 119. Celgene Paclitaxel Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Celgene Paclitaxel Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Celgene Recent Developments
Table 122. Jiangsu Hengrui Company Information
Table 123. Jiangsu Hengrui Description and Major Businesses
Table 124. Jiangsu Hengrui Paclitaxel Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Jiangsu Hengrui Paclitaxel Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Jiangsu Hengrui Recent Developments
Table 127. Bristol-Myers Squibb Company Information
Table 128. Bristol-Myers Squibb Description and Major Businesses
Table 129. Bristol-Myers Squibb Paclitaxel Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Bristol-Myers Squibb Paclitaxel Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Bristol-Myers Squibb Recent Developments
Table 132. Pfizer Company Information
Table 133. Pfizer Description and Major Businesses
Table 134. Pfizer Paclitaxel Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 135. Pfizer Paclitaxel Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Pfizer Recent Developments
Table 137. Teva Company Information
Table 138. Teva Description and Major Businesses
Table 139. Teva Paclitaxel Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 140. Teva Paclitaxel Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Teva Recent Developments
Table 142. Mylan Company Information
Table 143. Mylan Description and Major Businesses
Table 144. Mylan Paclitaxel Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 145. Mylan Paclitaxel Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Mylan Recent Developments
Table 147. Novartis Company Information
Table 148. Novartis Description and Major Businesses
Table 149. Novartis Paclitaxel Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 150. Novartis Paclitaxel Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Novartis Recent Developments
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Paclitaxel Drug Distributors List
Table 155. Paclitaxel Drug Customers List
Table 156. Paclitaxel Drug Market Trends
Table 157. Paclitaxel Drug Market Drivers
Table 158. Paclitaxel Drug Market Challenges
Table 159. Paclitaxel Drug Market Restraints
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Paclitaxel Drug Product Picture
Figure 2. Global Paclitaxel Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Paclitaxel Drug Market Share by Type in 2023 & 2030
Figure 4. 30mg Product Picture
Figure 5. 100mg Product Picture
Figure 6. Global Paclitaxel Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Paclitaxel Drug Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Drugs Store
Figure 10. Paclitaxel Drug Report Years Considered
Figure 11. Global Paclitaxel Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Paclitaxel Drug Revenue 2019-2030 (US$ Million)
Figure 13. Global Paclitaxel Drug Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 14. Global Paclitaxel Drug Revenue Market Share by Region (2019-2030)
Figure 15. Global Paclitaxel Drug Sales 2019-2030 ((K Units)
Figure 16. Global Paclitaxel Drug Sales Market Share by Region (2019-2030)
Figure 17. US & Canada Paclitaxel Drug Sales YoY (2019-2030) & (K Units)
Figure 18. US & Canada Paclitaxel Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 19. Europe Paclitaxel Drug Sales YoY (2019-2030) & (K Units)
Figure 20. Europe Paclitaxel Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 21. China Paclitaxel Drug Sales YoY (2019-2030) & (K Units)
Figure 22. China Paclitaxel Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 23. Asia (excluding China) Paclitaxel Drug Sales YoY (2019-2030) & (K Units)
Figure 24. Asia (excluding China) Paclitaxel Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Paclitaxel Drug Sales YoY (2019-2030) & (K Units)
Figure 26. Middle East, Africa and Latin America Paclitaxel Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 27. The Paclitaxel Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 28. The Top 5 and 10 Largest Manufacturers of Paclitaxel Drug in the World: Market Share by Paclitaxel Drug Revenue in 2023
Figure 29. Global Paclitaxel Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 30. Global Paclitaxel Drug Sales Market Share by Type (2019-2030)
Figure 31. Global Paclitaxel Drug Revenue Market Share by Type (2019-2030)
Figure 32. Global Paclitaxel Drug Sales Market Share by Application (2019-2030)
Figure 33. Global Paclitaxel Drug Revenue Market Share by Application (2019-2030)
Figure 34. US & Canada Paclitaxel Drug Sales Market Share by Type (2019-2030)
Figure 35. US & Canada Paclitaxel Drug Revenue Market Share by Type (2019-2030)
Figure 36. US & Canada Paclitaxel Drug Sales Market Share by Application (2019-2030)
Figure 37. US & Canada Paclitaxel Drug Revenue Market Share by Application (2019-2030)
Figure 38. US & Canada Paclitaxel Drug Revenue Share by Country (2019-2030)
Figure 39. US & Canada Paclitaxel Drug Sales Share by Country (2019-2030)
Figure 40. U.S. Paclitaxel Drug Revenue (2019-2030) & (US$ Million)
Figure 41. Canada Paclitaxel Drug Revenue (2019-2030) & (US$ Million)
Figure 42. Europe Paclitaxel Drug Sales Market Share by Type (2019-2030)
Figure 43. Europe Paclitaxel Drug Revenue Market Share by Type (2019-2030)
Figure 44. Europe Paclitaxel Drug Sales Market Share by Application (2019-2030)
Figure 45. Europe Paclitaxel Drug Revenue Market Share by Application (2019-2030)
Figure 46. Europe Paclitaxel Drug Revenue Share by Country (2019-2030)
Figure 47. Europe Paclitaxel Drug Sales Share by Country (2019-2030)
Figure 48. Germany Paclitaxel Drug Revenue (2019-2030) & (US$ Million)
Figure 49. France Paclitaxel Drug Revenue (2019-2030) & (US$ Million)
Figure 50. U.K. Paclitaxel Drug Revenue (2019-2030) & (US$ Million)
Figure 51. Italy Paclitaxel Drug Revenue (2019-2030) & (US$ Million)
Figure 52. Russia Paclitaxel Drug Revenue (2019-2030) & (US$ Million)
Figure 53. China Paclitaxel Drug Sales Market Share by Type (2019-2030)
Figure 54. China Paclitaxel Drug Revenue Market Share by Type (2019-2030)
Figure 55. China Paclitaxel Drug Sales Market Share by Application (2019-2030)
Figure 56. China Paclitaxel Drug Revenue Market Share by Application (2019-2030)
Figure 57. Asia Paclitaxel Drug Sales Market Share by Type (2019-2030)
Figure 58. Asia Paclitaxel Drug Revenue Market Share by Type (2019-2030)
Figure 59. Asia Paclitaxel Drug Sales Market Share by Application (2019-2030)
Figure 60. Asia Paclitaxel Drug Revenue Market Share by Application (2019-2030)
Figure 61. Asia Paclitaxel Drug Revenue Share by Region (2019-2030)
Figure 62. Asia Paclitaxel Drug Sales Share by Region (2019-2030)
Figure 63. Japan Paclitaxel Drug Revenue (2019-2030) & (US$ Million)
Figure 64. South Korea Paclitaxel Drug Revenue (2019-2030) & (US$ Million)
Figure 65. China Taiwan Paclitaxel Drug Revenue (2019-2030) & (US$ Million)
Figure 66. Southeast Asia Paclitaxel Drug Revenue (2019-2030) & (US$ Million)
Figure 67. India Paclitaxel Drug Revenue (2019-2030) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Paclitaxel Drug Sales Market Share by Type (2019-2030)
Figure 69. Middle East, Africa and Latin America Paclitaxel Drug Revenue Market Share by Type (2019-2030)
Figure 70. Middle East, Africa and Latin America Paclitaxel Drug Sales Market Share by Application (2019-2030)
Figure 71. Middle East, Africa and Latin America Paclitaxel Drug Revenue Market Share by Application (2019-2030)
Figure 72. Middle East, Africa and Latin America Paclitaxel Drug Revenue Share by Country (2019-2030)
Figure 73. Middle East, Africa and Latin America Paclitaxel Drug Sales Share by Country (2019-2030)
Figure 74. Brazil Paclitaxel Drug Revenue (2019-2030) & (US$ Million)
Figure 75. Mexico Paclitaxel Drug Revenue (2019-2030) & (US$ Million)
Figure 76. Turkey Paclitaxel Drug Revenue (2019-2030) & (US$ Million)
Figure 77. Israel Paclitaxel Drug Revenue (2019-2030) & (US$ Million)
Figure 78. GCC Countries Paclitaxel Drug Revenue (2019-2030) & (US$ Million)
Figure 79. Paclitaxel Drug Value Chain
Figure 80. Paclitaxel Drug Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies